BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £5, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | ||
Information Commissioner's Office |
||
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Decision Notice) [2012] UKICO FS50366396 (04 January 2012) URL: http://www.bailii.org/uk/cases/UKICO/2012/FS50366396.html Cite as: [2012] UKICO FS50366396 |
[New search] [Printable PDF version] [Help]
Summary: The complainant requested information about a specific clinical drug trial. The Medicines and Healthcare Products Regulatory Agency withheld the information under sections 40, 43 and 38. Subsequently the complainant confirmed that he did not want the information withheld under sections 38 and 40. The Commissioner-™s view is that the Medicines and Healthcare Products Regulatory Agency has not engaged section 43 and therefore the information withheld only under section 43 should be disclosed to the complainant. He also finds a breach of section 10 for a late response. This decision notice is currently under appeal to the Information Tribunal.
Section of Act/EIR & Finding: FOI 10 - Complaint Upheld, FOI 43 - Complaint Upheld